Ricevi le ultime notizie sulle azioni Bio-Rad Laboratories con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di BIO

Ultime notizie per

Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories Inc

Bioceres Crop Solutions Corp. - Ordinary Shares

Bioceres Crop Solutions Corp

Bioage Labs Inc

Blue Biofuels Inc

Bio Essence Corp

Biocept Inc

BIONITROGEN HLDGS CORP by BioNitrogen Holdings Corp.

BioNitrogen Holdings Corp

BioGaia AB

BIORA THERAPEUTCS INC by Biora Therapeutics, Inc.

Bio-Rad Laboratories, Inc. Class B Common Stock

Biosyent Inc

BIOASIS TECHNOLOGIES INC by Bioasis Technologies Inc.

Bioasis Technologies Inc

Biocept Inc COM PAR $0.0001 NEW 2023

BIOCARTIS GROUP NV by BIOCARTIS GROUP NV

Biome Grow Inc

Biolase Inc COM PAR $.001 NEW

Biolase Inc

Bioqual Inc

Biora Therapeutics Inc

BioPassport Token

SWEDISH ORPHAN BIOVIT ORD by Swedish Orphan Biovitrum AB

Swedish Orphan Biovitrum AB

Agilent Technologies

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Avantor

Azenta

BioLife Solutions

Bruker

Charles River Laboratories International, Inc. Common Stock

Charles River

Danaher

Icon

Illumina

IQVIA Hldgs

Medpace Hldgs

Mettler-Toledo International, Inc. Common Stock

Mettler-Toledo Intl

Qiagen

Repligen

Revvity

Sotera Health

Stevanato Group

Bio-Techne

Tempus AI

Thermo Fisher Scientific Inc Common Stock

Thermo Fisher Scientific

10x Genomics

Waters

West Pharmaceutical Services, Inc. Common Stock

West Pharmaceutical Servs

Bio-Rad Laboratories (BIO) Previsione

Notizie

Utili

Quote.Nav.option-chain

Guidance

Dividendi

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Commerci governativi

Rapporto azionario

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Comments

Bio-Rad Laboratories Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO